Healthcare & Life Sciences

Allogene

Allogene is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.

Activeseries-c-plus

View Full Profile Website

series-c-plus

Stage

Investors

About Allogene

Based in the United States, Allogene is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Allogene develops allogeneic CAR T cell therapies for the treatment of blood cancers, solid tumors, and autoimmune diseases using gene-engineering and gene-editing technologies to create off-the-shelf cell therapy products.

Explore Allogene's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing

Other Startups in United States

All startups →

All of USseed Allocore Allocateseries-c-plus Allocadiaseries-c-plus Allmark Door AllMade Materials Allogenicaseries-b Allonniaseries-a Alloraseries-b Allora Labsseed Allorion Therapeuticsseries-b Allosteros Therapeutics, Inc.